A Review of Recent Studies on the Effects of SARS-CoV-2 Infection and SARS-CoV-2 Vaccines on Male Reproductive Health
Overview
Authors
Affiliations
According to world statistics, men are more susceptible to the coronavirus disease 2019 (COVID-19) than are women. Considering the interconnection between infections and male infertility, investigation of the potential impact of COVID-19 on men's reproductive health is now a particularly relevant topic. Published data indicate decreased sperm quality and orchitis development in patients with COVID-19, including reduced sperm count, decreased sperm motility, and elevated DNA fragmentation index. Although mass vaccination against COVID-19 is currently being carried out worldwide using available authorized vaccines, the effect of these vaccines on men's reproductive health has not yet been investigated. There is currently no evidence that SARS-CoV-2 can be transmitted in semen, but available data suggest that it can infect spermatogonia, spermatids, Leydig cells, and Sertoli cells. Therefore, SARS-CoV-2 orchitis and reduced male fertility may be long-term complications of COVID-19, which requires further investigation. Currently, there is also no evidence that vaccines against SARS-CoV-2 have any pathological effects on spermatogenesis or male reproductive health. Thus, further studies are needed to determine the effects of COVID-19 and COVID-19 vaccines on men's reproductive health, which will help to optimize the management and rehabilitation of these patients. This review aims to discuss recent studies on the impact of the COVID-19 and COVID-19 vaccines on men's reproductive health. The article addresses various issues such as the effect of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) on testosterone biosynthesis, semen parameters, testicular tissue, and epididymis.
Yang T, Liu B, Luo X, Shen L, Xiao X, Wang Y Transl Androl Urol. 2024; 13(9):1835-1846.
PMID: 39434742 PMC: 11491219. DOI: 10.21037/tau-24-173.
Alzahrani M, Alkhani K, Alassaf A, Alorainy J, Binsaleh S, Almannie R Front Endocrinol (Lausanne). 2024; 14:1226858.
PMID: 38468633 PMC: 10925715. DOI: 10.3389/fendo.2023.1226858.
Rosas-Murrieta N, Rodriguez-Enriquez A, Herrera-Camacho I, Millan-Perez-Pena L, Santos-Lopez G, Rivera-Benitez J Viruses. 2024; 16(2).
PMID: 38400014 PMC: 10892376. DOI: 10.3390/v16020238.
The Effect of Long COVID-19 Infection and Vaccination on Male Fertility; A Narrative Review.
Pourmasumi S, Nazari A, Ahmadi Z, Kouni S, de Gregorio C, Koniari I Vaccines (Basel). 2022; 10(12).
PMID: 36560392 PMC: 9783106. DOI: 10.3390/vaccines10121982.
COVID-19 and Semen Fluid Parameters, a Retrospective Study from Infertility Clinics.
Al-Alami Z, Albeitawi S, ALNatsheh M, Albakri K, Qublan H, Muhaidat N Life (Basel). 2022; 12(12).
PMID: 36556441 PMC: 9781580. DOI: 10.3390/life12122076.